Implementation of 3D bioreactors to deliver expansion and patient access potential of allogeneic iPSC-derived cell therapies

Authors

• Chen-Yuan Kao, Century Therapeutics, USAFollow
• Tom Donnelly, Process Development, Century Therapeutics
• Christopher Deborde, Process Development, Century Therapeutics
• Kyle Smith, Process Development, Century Therapeutics
• Jason A. Mills, Process Development, Century Therapeutics
• Margaret Brennan, Process Development, Century Therapeutics
• Bruno Marques, Process and Product Development, Century Therapeutics

Conference Dates

April 27 - May 2, 2025

Abstract

Please click Additional Files below to see the full abstract

Recommended Citation

Chen-Yuan Kao, Tom Donnelly, Christopher Deborde, Kyle Smith, Jason A. Mills, Margaret Brennan, and Bruno Marques, "Implementation of 3D bioreactors to deliver expansion and patient access potential of allogeneic iPSC-derived cell therapies" in "Cell Culture Engineering XIX", A Khetan, BMS; Marcella Yu, Gilead; Mike Betenbaugh, Johns Hopkins University Eds, ECI Symposium Series, (2025). https://dc.engconfintl.org/cell_culture_engineering_xix/221